Filana Therapeutics Statistics
Total Valuation
FLNA has a market cap or net worth of $48.79 million. The enterprise value is -$33.89 million.
| Market Cap | 48.79M |
| Enterprise Value | -33.89M |
Important Dates
The last earnings date was Wednesday, July 29, 2026, before market open.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FLNA has 48.31 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | 48.31M |
| Shares Outstanding | 48.31M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.05% |
| Owned by Institutions (%) | 28.25% |
| Float | 47.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08
| Current Ratio | 2.08 |
| Quick Ratio | 2.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.78% and return on invested capital (ROIC) is -8.80%.
| Return on Equity (ROE) | -55.78% |
| Return on Assets (ROA) | -5.58% |
| Return on Invested Capital (ROIC) | -8.80% |
| Return on Capital Employed (ROCE) | -72.12% |
| Weighted Average Cost of Capital (WACC) | 0.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.11M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.24% in the last 52 weeks. The beta is -0.74, so FLNA's price volatility has been lower than the market average.
| Beta (5Y) | -0.74 |
| 52-Week Price Change | -53.24% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 43.75 |
| Average Volume (20 Days) | 347,696 |
Short Selling Information
The latest short interest is 6.24 million, so 12.91% of the outstanding shares have been sold short.
| Short Interest | 6.24M |
| Short Previous Month | 6.49M |
| Short % of Shares Out | 12.91% |
| Short % of Float | 13.18% |
| Short Ratio (days to cover) | 16.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | -15.66M |
| Operating Income | -10.67M |
| Pretax Income | -42.28M |
| Net Income | -42.28M |
| EBITDA | -45.02M |
| EBIT | -45.97M |
| Earnings Per Share (EPS) | -$0.88 |
Balance Sheet
The company has $82.68 million in cash and no debt, with a net cash position of $82.68 million or $1.71 per share.
| Cash & Cash Equivalents | 82.68M |
| Total Debt | n/a |
| Net Cash | 82.68M |
| Net Cash Per Share | $1.71 |
| Equity (Book Value) | 63.61M |
| Book Value Per Share | 1.32 |
| Working Capital | 43.57M |
Cash Flow
In the last 12 months, operating cash flow was -$29.79 million and capital expenditures -$581,000, giving a free cash flow of -$30.38 million.
| Operating Cash Flow | -29.79M |
| Capital Expenditures | -581,000 |
| Depreciation & Amortization | 984,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -30.38M |
| FCF Per Share | -$0.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FLNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.29% |
| Shareholder Yield | -0.29% |
| Earnings Yield | -86.66% |
| FCF Yield | -62.26% |
Analyst Forecast
The average price target for FLNA is $6.50, which is 543.56% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.50 |
| Price Target Difference | 543.56% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2017. It was a reverse split with a ratio of 1:7.
| Last Split Date | May 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |